Hepatitis C Treatment
With treatment, hepatitis C is curable. Recently, the treatment of hepatitis C has been revolutionized by the U.S. Food and Drug Administration’s approval of two new drugs for the treatment of the hepatitis C virus (HCV). This marks the first major breakthrough in the advance in HCV treatment in the last decade. With these new treatments, physicians expect that the cure rate for HCV will rise from 40 percent to approximately 70 percent or higher, especially for newly diagnosed or treatment naïve patients (patients who have never been treated before for HCV).
At Mount Sinai, we were proud to have played a major role in the approval of this new class of drugs, known as protease inhibitors. And today we remain committed to finding new drugs that will improve the cure rate in more patients with HCV.